UK biotech venture investment reaches five-year high of over £2bn

UK biotech companies secured £2.11bn in equity financing during the second quarter of 2026, marking the sector's strongest performance in five years. This investment confirms the UK's position as Europe's leading destination for biotech funding, accounting for 61% of the continent's total venture capital for the period.